Investigative Ophthalmology & Visual Science Cover Image for Volume 65, Issue 7
June 2024
Volume 65, Issue 7
Open Access
ARVO Annual Meeting Abstract  |   June 2024
Exploring molecular mechanisms of Müller glia phagocytosis using ligand-bound fluorospheres
Author Affiliations & Notes
  • Gavin Jozsef Gyimesi
    Biological Sciences, Fordham University, New York, New York, United States
  • Dmytro Shved
    Biological Sciences, Fordham University, New York, New York, United States
  • Mari Teli
    Biological Sciences, Fordham University, New York, New York, United States
  • Alan D Marmorstein
    Ophthalmology, Mayo Clinic Minnesota, Rochester, Minnesota, United States
  • Silvia C Finnemann
    Biological Sciences, Fordham University, New York, New York, United States
  • Footnotes
    Commercial Relationships   Gavin Gyimesi None; Dmytro Shved None; Mari Teli None; Alan Marmorstein None; Silvia Finnemann None
  • Footnotes
    Support  EY33188 Foundation Fighting Blindness
Investigative Ophthalmology & Visual Science June 2024, Vol.65, 1652. doi:
  • Views
  • Share
  • Tools
    • Alerts
      ×
      This feature is available to authenticated users only.
      Sign In or Create an Account ×
    • Get Citation

      Gavin Jozsef Gyimesi, Dmytro Shved, Mari Teli, Alan D Marmorstein, Silvia C Finnemann; Exploring molecular mechanisms of Müller glia phagocytosis using ligand-bound fluorospheres. Invest. Ophthalmol. Vis. Sci. 2024;65(7):1652.

      Download citation file:


      © ARVO (1962-2015); The Authors (2016-present)

      ×
  • Supplements
Abstract

Purpose : Retinal pigment epithelial (RPE) cells phagocytose photoreceptor outer segment fragments (POS) using a molecular mechanism that overlaps with pathways employed by other cells to phagocytose apoptotic debris. In vitro POS challenge is thus commonly used to assess phagocytic capacity by cells in culture. However, variability of POS characteristics, assay conditions, and quantification methods has hindered direct comparison of phagocytic activities across cell types or studies. Here, we optimize fluorescent beads bound with ligand proteins for known RPE phagocytic receptors to confirm their utility in RPE phagocytosis assays and define molecular characteristics of Müller cell clearance phagocytosis.

Methods : 1 μm-diameter fluorospheres were irreversibly bound with MERTK-ligand (PROS1) and/or αv integrin-ligand MFG-E8 (MFG), or albumin. RPE or Müller primary cells, ARPE-19 and MIO-M1 Müller cell lines were challenged with POS or beads, followed by immunoblotting, immunofluorescence microscopy, and fluorescence scanning quantification. αv integrin inhibitory peptide was added to select assays. Integrin antibodies were used to live label integrin surface receptors. Experiments were performed at least 3 times independently. Differences were deemed significant if p<0.05 by ANOVA or Student’s t-test.

Results : RPE cells phagocytosed ligand-bound beads like POS, with strong preference for combination of MFG+PROS1 over albumin or PROS1 alone. Integrin inhibition abolished POS uptake as expected, and similarly diminished MFG+PROS1-bead uptake by RPE (p<0.0001). RPE cells phagocytosed similar numbers of beads even if ligand-coated beads were stored at 4oC for up to 2 months. We observed both αvβ3 and αvβ5 integrins at the surface of MIO-M1 Müller glia, while RPE cells expressed only αvβ5 at their apical, phagocytic surface, as established previously. POS and bead uptake by MIO-M1 Müller cells was significantly increased by MFG+PROS1 as compared to albumin control (p<0.005). Integrin inhibition significantly reduced ligand-bead uptake (p<0.005). MFG+PROS ligand and integrin receptor dependence was shared by primary Müller glia.

Conclusions : Ligand-bound fluorospheres have utility as stable phagocytic particles that permit standardization across cell types and studies. Using these novel reagents, we found that primary and immortalized Müller glia in culture employ αv integrin receptors for clearance phagocytosis

This abstract was presented at the 2024 ARVO Annual Meeting, held in Seattle, WA, May 5-9, 2024.

×
×

This PDF is available to Subscribers Only

Sign in or purchase a subscription to access this content. ×

You must be signed into an individual account to use this feature.

×